Trimmed Business Impacts Schiff Nutrition 2Q As Expected

Trimmed Business Impacts Schiff Nutrition 2Q As Expected

SALT LAKE CITYSchiffNutrition International (NYSE:WNI) reported revenues and earnings decreases forits second quarter (2Q), noting the declines were largely expected due to thediscontinuance of certain private label business. Revenues for the quarter fell20 percent to $35.5 million, while net income slid to $1.5 million from $3.5million earned in 2Q last year.

Second quarter sales declined as expected, primarily due tothe discontinuance of certain private label business, said Bruce Wood,president and chief executive officer (CEO). Our branded sales also declinedslightly in the quarter, but they are up approximately 8 percent for the firstsix months. He further stated management is encouraged by the current overallstrong performance in its branded sales at the retail level, as measured byInformation Resources, Inc. and customer point of sale data.

We expect to build our branded sales with the fiscal thirdquarter introduction of new Move Free® Advanced Formula, he continued. Based on clinical research, we believe Move Free Advancedis superior to typical glucosamine chondroitin combination products, which havealready been proven effective in promoting joint health. He said Schiff (www.schiffnutrition.com) will be providingsubstantial marketing support for this proprietary new product, beginning in itsfiscal third quarter.